Results 151 to 160 of about 2,898,090 (272)

Near-optimal P300 speller performance using large language models: A multi-model analysis with performance bounds. [PDF]

PLoS One
Parthasarathy N, Soetedjo J, Panchavati S, Parthasarathy N, Lee D, Arnold C, Pouratian N, Speier W.   +7 more
europepmc   +1 more source

Using stacked autoencoders for the P300 component detection

Frontiers in Neuroinformatics, 2016
Vareka Lukas, Mautner Pavel
openaire   +1 more source

Ets2 Is an Activity‐Dependent Transcriptional Regulator of a Fast‐Twitch Muscle Program

The FASEB Journal, Volume 40, Issue 20, 31 October 2026.
Ets2 is a transcription factor rapidly (24 h) upregulated in skeletal muscle by fast 150 Hz, but not slow 20 Hz, stimulation patterns. Ets2 selectively translocates to nuclei of slow soleus muscle when stimulated by fast‐patterned, but not slow‐patterned, activity. Ets2 binds to a consensus DNA sequence in the troponin I fast intronic enhancer (TnIFIRE)
Zaheer A. Rana, Jo C. Bruusgaard, Jens R. Wendland, Ivan Winje, Ingrid M. Egner, Irina Karavanova, Einar Eftestøl, Detlef Vullhorst, Kristian Gundersen, Andres Buonanno   +9 more
wiley   +1 more source

Dissociable Trait Correlates of P300 Variability and Amplitude: Conscientiousness and Disinhibition. [PDF]

Psychophysiology
Jones DN, Bowyer CB, Martin CB, Patrick CJ, Joyner KJ.   +4 more
europepmc   +1 more source

Electrophysiological Correlates of Familial Dyslexia in Two Siblings: A Case Report. [PDF]

Diagnostics (Basel)
Sanfins MD, Silva DLDS, Donadon C, Skarzynski PH, Mello CB, Soares AJC.   +5 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, Volume 20, Issue 10, Page 2424-2448, October 2026.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, Volume 20, Issue 10, Page 2533-2566, October 2026.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source

Cognitive processing characteristics of the advantage of assistant referee offside decision-making: evidence from eye movements and ERPs. [PDF]

Front Psychol
Yang S, Ji Z, Zhang C, Wang L, Wang H.
europepmc   +1 more source

ADP‐ribosylation: An emerging regulator of the epigenome

Molecular Oncology, Volume 20, Issue 10, Page 2449-2465, October 2026.
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho, Chenqian Liu, W. Lee Kraus   +2 more
wiley   +1 more source

Maturational trajectories of neurophysiological indices of inhibitory control in typically developing children. [PDF]

Dev Cogn Neurosci
Aguilar-Ros A, Mateu-Yus B, Estorach-Segarra J, López-Sala A, Alonso I, Condominas E, Bachiller A, Mañanas MÁ, Fons C.   +8 more
europepmc   +1 more source